Mona Alibolandi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Top Venues

Molecular pharmaceutics

Biomaterials science

Journal of cellular physiology

Mashhad University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Mashhad University of Medical Sciences Mar 04 2015

Iran

PHD :: Pharmaceutical Research Center

Publications

Masoud Nejabat, Ali Samie, Amir Khojastehnezhad, Farzin Hadizadeh, Mohammad Ramezani, Mona Alibolandi, Khalil Abnous, Seyed Mohammad Taghdisi, Mohamed Siaj
Stimuli-Responsive Covalent Organic Frameworks for Cancer Therapy. ACS applied materials & interfaces (2024)
Zeinab Jan, Samaneh Mollazadeh, Khalil Abnous, Seyed Mohammad Taghdisi, Abolghasem Danesh, Mohammad Ramezani, Mona Alibolandi
Targeted Delivery Platforms for the Treatment of Multiple Sclerosis. Molecular pharmaceutics 19 (7) (2022)
Mohammad Ramezani, Vladimir P Torchilin, Seyed Mohammad Taghdisi, Khalil Abnous, Mohammad Ramezani, Mona Alibolandi
"Smart" self-assembled structures: toward intelligent dual responsive drug delivery systems. Biomaterials science 8 (21) (2021)
Setareh Sanati, Sahar Taghavi, Khalil Abnous, Seyed Mohammad Taghdisi, Maryam Babaei, Mohammad Ramezani, Mona Alibolandi
Fabrication of anionic dextran-coated micelles for aptamer targeted delivery of camptothecin and survivin-shRNA to colon adenocarcinoma. Gene therapy (2021)
Mahsa Zahiri, Maryam Babaei, Khalil Abnous, Seyed Mohammad Taghdisi, Mohammad Ramezani, Mona Alibolandi
Hybrid nanoreservoirs based on dextran-capped dendritic mesoporous silica nanoparticles for CD133-targeted drug delivery. Journal of cellular physiology 235 (2) (2019)